Director of Financial Planning and Analysis

Director of Financial Planning and Analysis

Veradermics is a late clinical-stage aesthetics and dermatology focused biopharmaceutical company developing first-in-class therapeutics for common dermatologic conditions. Fresh off a $75 million Series B financing, we are entering an exciting new chapter as we advance lead candidate VDPHL01, a non-hormonal oral therapeutic for androgenetic alopecia (AGA) and patterned hair loss (PHL). We are currently in late-stage Phase 2 development with Phase 3 preparations underway. Our pipeline also addresses conditions like common warts and molluscum contagiosum. Veradermics aims to redefine the standard of care in dermatology by combining scientific rigor with impactful innovation.

• You Can Be Part of a Meaningful Mission - Veradermics aims to create a paradigm shift in medical dermatology by bringing pharmaceutical innovation to skin conditions that lack meaningful therapeutic advances.
• Veradermics Has Significant Growth Potential – Product Candidates Have Cumulative Revenue Estimates of >

$6B / Year.

Director, FP&A | Position Overview

The Director of FP&A will serve as a hands-on leader and sole contributor initially, reporting directly to the CFO. This role will establish foundational FP&A processes, deliver accurate and timely insights, and serve as a trusted partner to executives and functional leaders. The position is highly visible, with significant impact on strategic decision-making and capital market readiness.

Analytics & Insights

Candidate Profile | Who You Are

Location

Salary and Benefits

Veradermics provides a comprehensive compensation package that includes a base salary, annual performance bonus eligibility, and access to the employee stock option plan. Robust benefits package including health coverage, retirement benefit matching, dependent care FSA, and unlimited paid time off.

Equal Opportunity Employer

#J-18808-Ljbffr